Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | heat shock protein 86, putative | 0.0045 | 0.0621 | 0.5 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.0065 | 0.1621 | 0.1066 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.1621 | 0.1066 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.024 | 1 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.022 | 0.9068 | 0.9006 |
Trypanosoma cruzi | Heat shock protein 83, putative | 0.0045 | 0.0621 | 0.0621 |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.0065 | 0.1621 | 0.1066 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.1621 | 0.1066 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.024 | 1 | 1 |
Onchocerca volvulus | 0.0065 | 0.1621 | 0.5 | |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.024 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 90, putative | 0.0045 | 0.0621 | 0.0621 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0082 | 0.2401 | 0.6564 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0065 | 0.1621 | 0.1066 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0045 | 0.0621 | 0.5 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0065 | 0.1621 | 0.1066 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.0065 | 0.1621 | 0.1066 |
Plasmodium falciparum | heat shock protein 90 | 0.0045 | 0.0621 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.024 | 1 | 1 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0082 | 0.2401 | 0.2401 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.024 | 1 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0101 | 0.3333 | 1 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0065 | 0.1621 | 0.1066 |
Onchocerca volvulus | Deterin homolog | 0.0065 | 0.1621 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.024 | 1 | 1 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.0065 | 0.1621 | 0.1066 |
Trypanosoma brucei | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0082 | 0.2401 | 0.1898 |
Trichomonas vaginalis | heat shock protein, putative | 0.0045 | 0.0621 | 1 |
Giardia lamblia | Heat shock protein HSP 90-alpha | 0.0045 | 0.0621 | 0.5 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.024 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0045 | 0.0621 | 0.0621 |
Plasmodium vivax | endoplasmin, putative | 0.0045 | 0.0621 | 0.5 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.024 | 1 | 1 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0045 | 0.0621 | 0.0621 |
Entamoeba histolytica | heat shock protein 90, putative | 0.0045 | 0.0621 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0065 | 0.1621 | 0.1066 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.022 | 0.9068 | 0.9006 |
Trypanosoma cruzi | heat shock protein 85, putative | 0.0045 | 0.0621 | 0.0621 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0082 | 0.2401 | 0.1898 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0065 | 0.1621 | 0.1066 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 65 nM | TR-FRET Assay | BINDINGDB. | No reference |
IC50 (binding) | = 22900 nM | TR-FRET Assay | BINDINGDB. | No reference |
IC50 (binding) | = 23465 nM | TR-FRET Assay | BINDINGDB. | No reference |
IC50 (binding) | = 26230 nM | TR-FRET Assay | BINDINGDB. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.